Lilly Responsibilities. (a) Subject to Sections 4.1.2(a) and 5.6, after IND Filing Readiness, Lilly will be responsible for all further Development activities for the initial Licensed Product, including filing of the IND for such initial Licensed Product; and will also be responsible for all research and Development activities with respect to any second or subsequent Licensed Products (collectively, the “Lilly Research Activities”). For clarity, subject to Sections 4.1.2(a) and 5.6 and without limiting Sigilon’s supply-related obligations hereunder (including under Sections 7.5 and 7.6) and under any other written agreement between the Parties, Sigilon shall have no obligation to assist in the development of or fund any activities with respect to any Licensed Products other than as expressly provided under the Research Plan, unless mutually agreed by the Parties in writing.
Lilly Responsibilities. Lilly will be responsible for all costs and expenses associated with the Lilly Research Activities.
Lilly Responsibilities. Lilly will be responsible for all Commercialization activities for the Products [**]
Lilly Responsibilities. Lilly will be responsible for all Commercialization activities for the Products [**] [**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.
Lilly Responsibilities. Prior to [**] in the People’s Republic of China, Lilly will be responsible for all Commercialization activities for the Products [**] except for the activities which Xxxxxxxxx shall be responsible for in the SOTC Areas as set forth in the 2018 Services and Demand Realization Agreement. Following [**] in the People’s Republic of China, Lilly will be responsible for all Commercialization activities for the Products in the Lilly Territory, and will be responsible for all Commercialization activities that do not constitute P&D Services for the Products in the Service Territory, except for the activities which Xxxxxxxxx shall be responsible for in the SOTC Areas as set forth in the 2018 Services and Demand Realization Agreement. [**] Xxxxxxxxx shall ensure its P&D Services are carried out in accordance with and in compliance with this Agreement and Regulatory Approvals and Applicable Laws. [**]
Lilly Responsibilities. Subject to FACILITY’S compliance with its responsibilities, LILLY will pay FACILITY an upfront discount off floating NWP during the term of the ENROLLMENT based on the discount schedule set forth below and as set forth in full in MMCAP contract MMS24153. Antidepressant Net Purchases (previous 6 months) Upfront Discount Percentage for Cymbalta® Greater than $35,000 5% Loss of eligibility to receive upfront discount shall be the sole remedy available for the failure of FACILITY to provide Equal and Unrestricted Formulary Status as described in ENROLLMENT. In the case of disputed payments, LILLY shall pay the undisputed amount subject to the terms of the ENROLLMENT and shall endeavor to resolve the dispute promptly.
Lilly Responsibilities. Lilly will be resnonsible for all Commercialization activities [**]
Lilly Responsibilities. Lilly will be responsible for the following:
Lilly Responsibilities. (a) Subject to Sections 4.1.2 and 2.4, Lilly will be responsible for the Research activities assigned to it in the Research Plan and for all further Research and Development activities for the Products other than Aduro Research Activities (collectively, the “Lilly Research Activities”). For clarity, subject to Sections 4.1.2 and 2.4 and under any other written agreement between the Parties, Aduro shall have no obligation to assist in the Development of or fund any activities with respect to any Products other than as expressly provided under the Research Plan, unless mutually agreed by the Parties in writing. [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Lilly Responsibilities
